Valeant Pharmaceuticals International (VRX) Highlights Taribavirin Phase IIb End of Study Data Presentation at American Association for the Study of Liver Disease (AASLD) Annual Meeting
11/3/2009 8:28:54 AM
More...
|
Valeant Pharmaceuticals International (VRX) to Acquire Polish Products for $18 Million
10/30/2009 6:21:30 AM
More...
|
Valeant Pharmaceuticals International (VRX): New Study Assesses Skin Hydration and Epidermal Function of 2.5% and 5% Benzoyl Peroxide-Clindamycin Combinations
10/20/2009 9:05:41 AM
More...
|
Valeant Pharmaceuticals International (VRX) To Buy Australian Skin-Care Company For $73.4 Million
9/30/2009 6:45:37 AM
More...
|
Valeant Pharmaceuticals International (VRX) Buys-Out Rights to All Current and Future Income and Milestone Obligations From Former Dow Pharmaceutical Sciences (JOBS) Stockholders for $115M
9/29/2009 9:15:17 AM
More...
|
Valeant Pharmaceuticals International (VRX) Provides Update on Retigabine
9/21/2009 8:44:06 AM
More...
|
Valeant Pharmaceuticals International (VRX) CEO's Pay Package Draws Praise as a Model
8/24/2009 11:44:00 AM
More...
|
Valeant Pharmaceuticals International (VRX)'s Pain Drug Fails in Mid-Stage Trial
8/24/2009 8:00:52 AM
More...
|
Valeant Pharmaceuticals International (VRX) Q2 Profit Beats Street, Ups '09 Earnings View
8/4/2009 6:41:56 AM
More...
|
Valeant Pharmaceuticals International (VRX) to Acquire Tecnofarma, A Mexican Generic Company
7/29/2009 7:40:40 AM
More...
|
|